🇺🇸 FDA
Patent

US 6921765

1-Azabicyclo[2.2.2]octan-3-one derivatives and maleimide derivatives and their use for treating cancer tumors

expired A61PA61P35/00

Quick answer

US patent 6921765 (1-Azabicyclo[2.2.2]octan-3-one derivatives and maleimide derivatives and their use for treating cancer tumors) held by APREA AB expires Mon Jul 21 2025 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
APREA AB
Grant date
Tue Jul 26 2005 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 21 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
2
CPC classes
A61P, A61P35/00